<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors examined cognition and functional health of 57 patients with sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> 1 year or more after enrollment in a randomized trial of <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment or placebo </plain></SENT>
<SENT sid="1" pm="."><plain>Eight patients died and two declined participation </plain></SENT>
<SENT sid="2" pm="."><plain>Of the remaining 47 patients, 16 (35%) had <z:hpo ids='HP_0100543'>cognitive impairments</z:hpo>, 3 (6%) were dependent, 19 (40%) had symptoms that led to restrictions in lifestyle, and 19 (40%) could not resume their previous level of economic activity </plain></SENT>
<SENT sid="3" pm="."><plain>Outcome after sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> may be less favorable than reported previously, and was not significantly influenced by treatment </plain></SENT>
</text></document>